Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer
- 30 April 1999
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 52 (4), 291-292
- https://doi.org/10.1054/mehy.1998.0009
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cyclooxygenase-2 gene expression in human breast cancerInternational Journal of Oncology, 1997
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.Endocrinology, 1996
- Cyclooxygenase 2 induction: Molecular mechanism and pathophysiologic rolesJournal of Laboratory and Clinical Medicine, 1996
- Nonsteroidal Antiinflammatory Drugs and Breast CancerEpidemiology, 1996
- Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesisFEBS Letters, 1995
- Effects of gamma-linolenic and dihomo-gamma-linolenic acids on 7,12-dimethylbenz(α)anthracene-induced mammary tumors in ratsProstaglandins, Leukotrienes & Essential Fatty Acids, 1995
- Breast Cancer and NSAID Use: Heterogeneity of Effect in a Case-Control StudyPreventive Medicine, 1995
- Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective StudyEpidemiology, 1994
- Plant and marine n-3 fatty acids inhibit experimental metastasis of rat mammary adenocarcinoma cellsProstaglandins, Leukotrienes & Essential Fatty Acids, 1993
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971